Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical ...

The peer-reviewed publication this week in Nature Publishing Cell Death & Disease(1) provides compelling support for the hypothesis that iron dysregulation is not merely a bystander, but a potential ...

Prior research has suggested that 7% to 8% of patients with AMD develop hemorrhagic complications. In this study, the use of anticoagulants or antiplatelets was linked to a higher risk of intraocular ...

Background/aims To find biomarkers on OCT-angiography (OCT-A) that indicate a higher risk of recurrence in neovascular age-related macular degeneration (nAMD) patients before anti-vascular endothelial ...

On the occasion of 'World Sight Day,' a leading ophthalmologist is highlighting two major but often overlooked eye conditions: age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Imaging technologies like OCT and FAF are essential for diagnosing and monitoring GA, with OCT aiding in early intervention ...

Details of Ashvattha's presentation is as follows: ...

Patients with age-related macular degeneration may have “transient” adverse macular changes after cataract surgery, but these ...

Abstract: Miniature rotation actuators have been extensively developed and utilized in optical coherence tomography (OCT) endoscopy, enabling distortion-free OCT imaging in complex and tortuous ...

Cirrus Therapeutics, an ocular immunology-focused biotech, announced today the close of an $11 million seed financing to advance its pipeline of gene and cell therapies aimed at improving quality of ...

Researchers evaluated whether a deep learning model could distinguish between autoimmune neuroinflammatory disorders based on ...